≡ Menu

Public Notification: “RigiRx Plus” Contains Undeclared Drug Ingredient

A Dietary Supplement Recall or Safety Alert Has Been Issued: Public Notification: “RigiRx Plus” Contains Undeclared Drug Ingredient. According to the Food & Drug Administration FDA:

The Food and Drug Administration (FDA) is advising consumers not to purchase or use “RigiRx Plus,” a product for sexual enhancement manufactured by Enhance Nutraceutical, and sold on various websites, including www.rigirxplus.com. FDA laboratory analysis confirmed that “RigiRx Plus” contains aminotadalafil. Aminotadalafil is an analog of tadalafil, an FDA approved prescription drug used to treat Erectile Dysfunction (ED).

For more information on the dietary supplement recall or safety alert, read the Food & Drug Administration’s FDA’s dietary supplement recall or safety alert: Public Notification: “RigiRx Plus” Contains Undeclared Drug Ingredient.

To report an adverse reaction, problem or other issue with a dietary supplement, submit a complaint to the government at fda.gov or MedWatch

If you have thoughts on the dietary supplement recall or safety alert, share your dietary supplement recall or safety alert comments below.

{ 0 comments… add one }

Leave a Comment